Markets.com Logo

LIDDS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.0651$
  • Previous Close
    0.0841$
  • 52 Week Change
    0.20$
  • Day Range
    -0.02$
  • 52 Week High/Low
    0.0304$ - 0.23$
  • Dividend Per Share
    --
  • Market cap
    9 552 K$
  • EPS
    -0.0096
  • Beta
    0.262
  • Volume
    --

About

LIDDS AB (LIDDS.ST) is a Swedish pharmaceutical company that develops innovative drug delivery systems. Their proprietary NanoZolid technology allows for controlled and sustained release of drugs directly into tumors or other tissues. LIDDS is primarily focused on oncology, with clinical-stage programs targeting prostate cancer and other solid tumors. The company's stock is traded on the Nasdaq First North Growth Market in Stockholm under the ticker symbol LIDDS.ST. Their focus is on improving treatment efficacy and reducing side effects through targeted drug delivery.

Gold Volatility: Is a Structural Shift Underway? An In-depth Analysis

Noah Lee|--

S&P 500's Record Rally Continues: Nomura Strategist Flags Two Key Exit Signals

Liam James|--

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Global Markets Show Resilience Amidst Iran Conflict, But Underlying Risks Persist

Emma Rose|--

Iran War Threatens US Labor Market's 'Wonderful Balance': A Deep Dive

Emma Rose|--

Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment

Sophia Claire|--

US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks

Sophia Claire|--

Factors

Company Performance: LIDDS.ST's financial health and growth prospects greatly influence its stock price. Positive earnings reports, successful clinical trials, and promising pipeline developments can boost investor confidence.

Market Sentiment: General market trends and investor psychology play a significant role. Positive overall market conditions and optimism towards pharmaceutical stocks can drive LIDDS.ST's price upward.

Regulatory Approvals: Approval of LIDDS's pharmaceutical products by regulatory bodies like the EMA or FDA is a crucial catalyst. Approvals significantly de-risk the investment and validate the technology.

Competition: The competitive landscape within the drug delivery and oncology sectors impacts LIDDS.ST's valuation. The presence of competing technologies or successful products can negatively affect the stock.

Industry Trends: Overall trends in drug development, personalized medicine, and targeted therapies influence the demand for LIDDS.ST's technology. Rising interest in these areas can increase investor appetite.

Management Team: The experience and reputation of LIDDS.ST's leadership team affect investor trust. Competent management inspires confidence and positive sentiment.

Partnerships and Collaborations: Collaborations with larger pharmaceutical companies or research institutions can validate LIDDS.ST's technology and provide access to resources, impacting the stock price.

Clinical Trial Results: Results from clinical trials of LIDDS's drug candidates are major drivers of stock price movements. Positive trial data indicating efficacy and safety can lead to significant gains.

Economic Factors: Broader economic conditions, such as interest rates and inflation, can affect investor appetite for riskier assets like pharmaceutical stocks, indirectly impacting LIDDS.ST.

Investor Relations: Effective communication with investors and transparency about the company's progress are essential for maintaining confidence and positively influencing the stock price.

People Also Watch

Latest news

Japan's Central Bank Poised for Rate Hike Amidst Heightened Middle East Tensions

Ava Grace|--

US Stocks Hit Record Highs as Geopolitical Fears Ease, Tech Bet Surge

Ava Grace|--

Fed Chair Succession Sparks Legal Battle Over Independence

Noah Lee|--

Latest Education Articles

Gold or Silver CFDs? Key Differences Every CFD Trader Should Know

Gold or Silver CFDs? Key Differences Every CFD Trader Should Know

Julian Parker|--
Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Julian Parker|--
Recommended Topics